February 16, 2026 Food pyramid backlash: Low-fat era may have fueled obesity, diabetes, says doctor Dr. Mark Hyman calls new nutrition guidelines "revolutionary" for targeting processed foods and sugar drinks, despite dairy and protein concerns for some groups.
February 10, 2026 Common diabetes drug may help preserve eyesight as people age Breakthrough research shows diabetes medicine metformin may reduce age-related vision loss by 37%. Liverpool study offers hope for AMD treatment.
January 29, 2026 Alzheimer’s risk tied to how the body handles sugar after eating, study finds Genetic study reveals that people who have elevated blood glucose two hours after eating face significantly higher Alzheimer's disease risk. University of Liverpool researchers analyzed data.
January 25, 2026 Nearly 90% of Americans at risk of silent disease — here's what to know Mixed news for heart health: fewer heart attacks but rising stroke deaths among young adults. Study reveals 90% of U.S. adults have cardiovascular risks.
January 24, 2026 1 in 5 Americans get no exercise outside of work; where does your state rank? One in five Americans get zero physical activity outside work, with Mississippi leading inactivity at 30.6%. Colorado ranks as most active at just 15.6%.
January 17, 2026 GLP-1 drugs require lifestyle change to work long term as expert warns of potential 'danger' Fox News senior medical analyst Dr. Marc Siegel discusses the benefits and risks of GLP-1 medications on 'Fox & Friends Weekend.'
January 17, 2026 Sugar alternative bakes like real thing and with far fewer calories, researchers insist A newly developed sugar alternative tastes 92% like real sugar, scientists say, but with 60% fewer calories and minimal blood sugar impact. Experts share more details.
January 14, 2026 Eating leftover pasta may be better for your blood sugar than consuming a fresh bowl, experts say Experts explain why reheated pasta creates resistant starch that acts like fiber, potentially reducing blood sugar and feeding good gut bacteria, and how to get the most out of the trick.
January 12, 2026 What are GLP-3s? Meet the new generation of weight-loss drugs with three key ingredients Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the improvement of other conditions in longer studies.
January 9, 2026 Weight-loss experts predict 5 major treatment changes likely to emerge in 2026 Weight-loss experts reveal their major predictions for 2026, from advanced GLP-1 treatments to AI-driven personalized therapy and minimally invasive procedures.